Meridigen Biotech
Meridigen Biotech is a company focused on the research and development of stem cell-based therapeutic drugs, particularly those derived from human umbilical cord mesenchymal stem cells (hUC-MSCs). They have developed a unique platform for MSCs characterization and large-scale manufacturing, aiming to create breakthroughs in treating diseases like bronchopulmonary dysplasia, cerebral palsy, ischemia stroke, COPD, and ARDS. The company also offers contract research services, including trial design, outsourcing experiments, and testing services, leveraging their multidisciplinary biomedical professionals and advanced equipment. Meridigen is actively involved in patenting and publications related to their stem cell technologies.
Meridigen Biotech
Meridigen Biotech is a company focused on the research and development of stem cell-based therapeutic drugs, particularly those derived from human umbilical cord mesenchymal stem cells (hUC-MSCs). They have developed a unique platform for MSCs characterization and large-scale manufacturing, aiming to create breakthroughs in treating diseases like bronchopulmonary dysplasia, cerebral palsy, ischemia stroke, COPD, and ARDS. The company also offers contract research services, including trial design, outsourcing experiments, and testing services, leveraging their multidisciplinary biomedical professionals and advanced equipment. Meridigen is actively involved in patenting and publications related to their stem cell technologies.